Form 4 for PTCT PTC THERAPEUTICS, INC.
Accepted 2025-05-19 00:00:00 ET · period of report 2025-05-15 · accession 0001415889-25-013661 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-05-19 | 2025-05-15+ | PTCT | Boulding Mark Elliott | EVP AND CLO | S - Sale+OE | $46.13 | -2,812 | 103.9K | -3% | -$129.7K |
| DM | 2025-05-19 | 2025-05-15+ | PTCT | Boulding Mark Elliott | EVP AND CLO | M - OptEx | $25.69 | +2,812 | 105.8K | +3% | +$72.2K |
| DM | 2025-05-19 | 2025-05-15+ | PTCT | Boulding Mark Elliott | EVP AND CLO | M - OptEx | $0.00 | -2,812 | 27.7K | -9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-16 | S | D | 883 | $46.02 | 103,901 | D | — | — | (F3) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $46.00 to $46.19 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2025-05-16 | M | A | 883 | $25.69 | 104,784 | D | — | — | |
| 3 | Common | Common Stock | 2025-05-15 | M | A | 1,929 | $25.69 | 105,830 | D | — | — | |
| 4 | Common | Common Stock | 2025-05-15 | S | D | 1,929 | $46.18 | 103,901 | D | — | — | (F2) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $46.00 to $46.61 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 5 | Derivative | Stock Option (Right to Buy) | 2025-05-15 | M | D | 1,929 | $0.00 | 28,595 | D | $25.69 · — to 2034-02-14 | 1,929 Common Stock | (F4) This option was granted on February 14, 2024 and vests over four years, with 25% of the shares underlying the option vested on February 15, 2025, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on May 15, 2025. |
| 6 | Derivative | Stock Option (Right to Buy) | 2025-05-16 | M | D | 883 | $0.00 | 27,712 | D | $25.69 · — to 2034-02-14 | 883 Common Stock | (F4) This option was granted on February 14, 2024 and vests over four years, with 25% of the shares underlying the option vested on February 15, 2025, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on May 15, 2025. |